CC
LKFT

Centiva Capital’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Centiva Capital’s Portfolio LKFT Stock Details LKFT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-75,000
Closed -$2.1M – 1380
2025
Q2 		$2.1M Sell
75,000
-77,000
-51% -$2.06M 0.03% 335
2025
Q1 		$3.82M Buy
+152,000
New +$3.84M 0.12% 87

Other funds holding LKFT

GS
Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return
DCM
DME Capital Management New York $3.19B AUM 23.22% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Centiva Capital's LKFT Position: Q3 2025 in Review

Centiva Capital sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q3 2025, closing a stake of 94,905 shares — an estimated $2.66M sold.

Centiva Capital first reported a position in LKFT in Q1 2025 and held it in 2 quarters. The position peaked at $2.66M in Q2 2025. 92 funds tracked by Wall St. Rank hold LKFT as of Q3 2025.

  • Centiva Capital reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q3 2025 after selling out during the quarter.
  • Centiva Capital sold 94,905 Lakefront Biotherapeutics American Depositary Shares shares in Q3 2025, an estimated $2.66M.
  • Centiva Capital first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q1 2025 and held it in 2 quarters.
  • Centiva Capital's Lakefront Biotherapeutics American Depositary Shares position peaked at $2.66M in Q2 2025.
  • 92 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q3 2025.

Based on Centiva Capital's 13F filing for Q3 2025, filed 14 Nov 2025.